Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis: Results from a Multicenter RCT
A double-blind, randomized controlled trial across 26 sites found that daily n-3 fatty acid (fish oil) supplementation significantly lowered the risk of serious cardiovascular events in hemodialysis patients, with a favorable safety profile.